- GPC Biotech AG
- GPC Biotech Inc.
- Fougera Pharmaceuticals Inc.
- Altana AG
- Boehringer Ingelheim International GmbH
- Sygnis AG
- Aventis SA
- Bayer AG
- DuPont Pharmaceuticals Co.
- Atugen AG
- Evotec SE
- Maxim Pharmaceuticals Inc.
- Karo Pharma AB
- Takeda Oncology
- CuraGen Corp.
- MorphoSys AG
- Johnson & Johnson
- Janssen Products LP
- GPC AG to buy Mitotix in all-stock deal
- Byk Gulden in functional genomics deal with GPC Biotech
- Boehringer Ingelheim, GPC Biotech to discover therapy for HPV
- GPC, BI Austria in research collaboration for cancer targets
- Bayer licenses Millennium's discovery technology for $465mm
- Aventis, Millennium sign $450mm anti-inflammatory drug deal
- Bayer enters major alliance with CuraGen
- MorphoSys to develop HuCAL antibodies for Centocor
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.